logo-loader

NA Proactive news snapshot: Duos Technologies, Lydian International, CytoDyn, BevCanna Enterprises ...

Last updated: 17:45 14 Aug 2019 EDT, First published: 10:00 14 Aug 2019 EDT

Duos Technologies Group, Inc -

Duos Technologies Group Inc (OTCQB:DUOT) reported record revenue in the first half of 2019, thanks to substantial and ongoing growth in the project portion of its business.  In the six months until June 30, 2019, the Jacksonville, Florida-based company’s revenue climbed to $5.7 million from $4.4 million in the year-ago period. For 2Q, Duos reported revenue of $1.35 million, compared to $3.24 million in the same period a year ago, due to customer construction delays which led to timing shifts.

Earlier Duos Technologies had revealed that its operating subsidiary has secured a contract worth $2.3 million from a Class 1 freight rail operator. In a statement, the Jacksonville, Florida-based technology company which serves the $60 billion North American rail market, said the customer will be adopting the latest version the company’s Railcar Inspection Portal (RIP). The award includes a five-year contract for tech support and development of artificial intelligence algorithms to automate the client’s railcar inspection process.

Lydian International Ltd (TSE:LYD) (OTCMKTS:LYDIF) shares jumped Wednesday after the gold miner said an environmental audit on its Amulsar project in Armenia has been released by a special investigative committee of the Republic of Armenia. In a statement, the Toronto-based company also noted that, in a televised interview, the head of the Department for Investigation of Corruption-related Property Crimes and Cybercrimes of the special investigative committee, Yura Ivanyan, said there were no grounds for criminal charges.

CytoDyn Inc (OTCMKTS:CYDY) announced Wednesday that a human immunodeficiency virus (HIV) monotherapy dose escalating trial with its flagship drug leronlimab (PRO 140) topped expectations. In a statement, the Vancouver-based company said HIV-infected patients received 350 mg, 525 mg, or 700 mg of leronlimab once a week with 150 patients showing “sustained viral suppression” after a year of monotherapy.

BevCanna Enterprises Inc (CSE:BEV) (OTCMKTS:BVNNF), a cannabis-infused beverage producer, announced promising results Wednesday from independent tests of its powdered cannabis ingredient Deeper Green. The tests found that Deeper Green, which BevCanna uses to infuse beverages with cannabinoids, meets the Cannabis Compliance Regulations in California. The water-soluble powder was shown to deliver target concentrations of THC, which provides consumers with confidence that they’re getting the correct dose.

XPhyto Therapeutics Corp (CSE:XPHY) (FSE:4XT) has signed a new agreement in Germany that will enhance the science-focused cannabis company’s research and development initiatives. The Vancouver-based company announced Wednesday that it had entered into an exclusive agreement with the Technical University of Munich’s biochemistry department to research novel approaches to utilize the cannabis plant and its derivatives.

Chanticleer Holdings Inc (NASDAQ:BURG), an operator of multiple regional burger chains, posted second-quarter results after the bell Wednesday that showed growing revenue but widening losses as it closed underperforming units and positioned for a second half improvement. The company brought in revenue of $10.7 million, up $400,000 year over year albeit lower than the consensus estimates of $11.2 million. Its operating loss was $3 million, or $0.83 per share, versus $420,000, $0.23 per share, a year ago. Analysts were calling for a decline of $0.26 per share. 

Arcadia Biosciences Inc. (NASDAQ:RKDA) president and CEO, Raj Ketkar said the company expects to “significantly scale revenues in 2020” as it reported financial and business results for the second quarter and first half of 2019. Arcadia’s net income for the second quarter of 2019 was $4.2 million, a 164% year-on-year increase.

Maverix Metals Inc (CVE:MMX) (OTCMKTS:MACIF) has increased its royalty interest in a world-class gold camp in Canada, namely the Hope Bay mine in Nunavut, owned and operated by TMAC Resources Inc (TSE:TMR). Maverix currently owns an existing 1% net smelter royalty (NSR) on the Hope Bay gold mine but the firms' have now agreed that Maverix will acquire a further 1.5% NSR (additional royalty) with effect from August 1 this year for a cash payment of US$40 million, bringing it up to a combined 2.5% NSR.

Verde Agritech PLC (TSE:NPK) (OTCMKTS:AMHPF), the fertilizer producer, said construction of its expanded plant will be finalized by the third quarter of 2019 as it reported the continued rise in output of its Super Greensand product. For the first half of the year to June 30, the firm sold 24,670 tonnes of Super Greensand for C$1.48 million in revenue as it advanced the project in Brazil.

Carube Copper Corp (CVE:CUC) said it has completed a new completed a mapping and sampling program on its Mackenzie project in southwestern British Columbia. The Mackenzie property is a 125-square-kilometre area where previous work by Carube Copper and its predecessor Miocene Metals identified three copper-bearing trends. Carube’s current exploration on the project is focused on two of the areas, the Bornite and Breccia trend prospects. The company said on Wednesday that 40 samples have been submitted for assay.

Cannabis companies Harvest One Cannabis Inc (CVE:HVT) (OTCMKTS:HRVOF) and WeedMD Inc (CVE:WMD) (OTCMKTS:WDDMF) have hailed the successful completion of the first phase of a pilot program to verify and track medicinal cannabis with the help of Canada’s largest pharmacy, Shoppers Drug Mart. The program is being undertaken in conjunction with TruTrace Technologies Inc’s (CSE:TTT) (OTCMKTS:TTTSF) StrainSecure platform, a blockchain-enabled technology that is designed to increase the transparency and validation of products within the medical cannabis industry.

Telson Mining Corporation (CVE:TSN) (OTCMKTS:SOHFF) is shifting its focus to the company’s 100%-owned Tahuehueto gold project in Durango State, Mexico, the miner announced Wednesday afternoon. The company’s flagship asset, Tahuehueto is a district-scale epithermal mineralized system that Telson believes has the capability to become a substantial gold asset.

Global Atomic Corporation (CVE:GLO) announced Wednesday that partner Befesa Zinc SAU has resumed operations at its processing plant in Iskenderun, Turkey after completing a successful expansion project.  The Toronto-based company has a 49% interest in the Befesa Silvermet zinc concentrate production facility in Turkey and is advancing the DASA uranium deposit in Niger.

American Battery Metals Corporation (OTCQB:ABML), which is focused on the Railroad Valley lithium project in Nevada, said August has been an exciting period for the company and revealed it is planning a formal reserve report for the project. In a shareholder update, the firm said it was "heating up and we have had a busy summer so far!"

Alternus Energy Inc (OTCMKTS:ALTN) has started officially reporting to the US Securities Exchange Commission (SEC) as of Tuesday, the company announced. The solar energy operator said it had voluntarily filed Form 10 with the SEC, registering its common stock under the Securities Exchange Act of 1934. Going forward, the company will be required to file annual 10-K forms and quarterly 8-K forms, among other items.  The move is part of Alternus’ plan to uplist to the NYSE or Nasdaq in New York.

Ascent Industries Corp (CSE:ASNT) updated shareholders on Wednesday on the status of its bi-weekly default reports in accordance with its continuous disclosure requirements. The cannabis company said that there were no material changes since its last news release on July 30 and confirmed that there have been no failures in fulfilling its intention to satisfying the provisions of the alternative information guidelines under NP 12-203. Ascent said in intends to file its annual filings as soon as possible.

Analysts at Noble Research remain optimistic on Dyadic International Inc (NASDAQ:DYAI) following the firm's recent second quarter results, reaffirming an Outperform rating and a $9 price target on the stock.  On Tuesday, the company posted research and development revenue of $391,000, up from $161,000 for the same period in 2018, and a loss of $0.10 per share, wider than its $0.08 loss last year. In a note to clients, Noble's analysts said the current financials were in line with their estimates and, therefore, they are maintaining their estimates for revenue of $1.5 million, $1.6 million, and $1.7 million for full-years 2019, 2020, and 2021, respectively.

Harvest One Cannabis Inc (CSE:HVT) said the TSX Venture Exchange has accepted for filing the company's proposal to issue 313,710 shares at a deemed price of 57 cents to an arm's-length service provider in consideration of certain services provided to the company pursuant to an agreement dated June 21, 2019.

VR Resources Ltd. (CVE:VRR) ( OTCBB:VRRCF) said, after the close, that it has filled and completed its previously announced non-brokered private placement of 2,200,000 units at a price of $0.22 per unit for aggregate proceeds of $484,000. Each Unit consists of one common share  of the company and one-half of a common share purchase warrant.  Each whole warrant will entitle the holder to acquire one additional common share at an exercise price of $0.40 per common share for a period of 18 months from the closing date of the financing.

Capstone Turbine Corporation (NASDAQ:CPST) has announced that its Signature Series C200 and C1000, and C65 energy systems have become the first microturbines to be certified to the United Kingdom Energy Networks Association (ENA) G99 grid connection standard. In a statement, the leader in clean technology manufacturer of microturbine energy systems pointed out that the global momentum towards the adoption of grid interconnection standards for distributed energy resources continues at full speed.

Acasti Pharma Inc (CVE:ACST) (NASDAQ:ACST) said it is on track to report topline results from the first phase of clinical trials on its CaPre prescription drug candidate by the end of the year, with phase two due early in 2020. The news came as the company released fiscal first quarter results Wednesday that highlighted a number of recent developments in the biopharmaceutical company’s quest to put CaPre on the market to combat severe hypertriglyceridemia.

Biome Grow Inc (CSE:BIO) (OTCMKTS:BIOIF) is bringing its cannabis products to Manitoba, the company announced Wednesday. The company has won a license for the retail sale of cannabis in the province and plans to distribute its select dried flower and pre-rolls to retailers from its wholly-owned Nova Scotia cultivation facility, Highland Grow. The news follows similar approvals in Saskatchewan and New Brunswick, bringing the company’s total distribution area to five provinces, also including Newfoundland and Labrador and Nova Scotia.

Lexaria Bioscience Corp (CSE:LXX) (OTCMKTS:LXRP), the biotechnology company behind the drug delivery system DehydraTECH, tapped a new director on Wednesday who recently left one of its major business partners. The company announced that Brian Quigley, a 16-year veteran of Altria Group, would be joining its board. Quigley spent a combined 7 years as CEO of Altria's subsidiaries US Smokeless Tobacco and then Nu-Mark, while an investment deal between the tobacco giant and Lexaria was being negotiated.

TruTrace Technologies Inc (CSE:TTT) (OTCMKTS:TTTSF) hit another milestone in its partnership with Shoppers Drug Mart to increase transparency and product identification of medical cannabis. The Toronto-based company said on Wednesday that it had successfully completed the first phase of the blockchain-secured pilot program and will move forward with the second phase in preparation for full implementation of TruTrace’s StrainSecure platform.

TIMIA Capital Corp (CVE:TCA) (OTCMKTS:TIMCF) revealed that its previously announced US$1 million financing for tech group Real Savvy Inc has been paid out - generating a 20% return to Timia in ten months. TIMIA Capital is a specialty finance company, which provides growth capital to tech firms in exchange for payments based on monthly revenue.

Ximen Mining Corp (CVE:XIM) told investors that its option partner New Destiny Mining Corp (CVE:NED) is set to drill at the Treasure Mountain silver property, British Columbia, following encouraging recent sample results. In an initial program of rock chip sampling, assays ranged from up to 1.6% copper, 0.87 grams per tonne (g/t) gold and 109 g/t silver on one sample at the Superior (Lucky Todd) prospect. New Destiny is now mobilizing a diamond drill rig to further test the Superior (Lucky Todd) and Railroad Creek prospects with scout holes across mineralized zones.

Maverix Metals Inc (CVE:MMX) (OTCMKTS:MACIF) has reported another period of growth with increases in revenue and net income in its second quarter. In a statement, the precious metals royalty and streaming firm said its net income for the three months to end June came in at C$819,000, compared to a loss of C$458,000 in the same period a year earlier. Total revenue was C$9.3million compared to C$8.4million in the second quarter of 2018, added the firm, which holds a portfolio of 80 royalties and streams across 16 countries.

Orgenesis Inc. (NASDAQ: ORGS) has transferred ownership of its Israeli cell process development business, Atvio Biotech Ltd., and its South Korean cell development and manufacturing business, CureCell Co., Ltd. from its subsidiary, Masthercell Global, to the parent company.  In a statement, the leading cell and gene therapy company said Atvio and Curecell will provide internal manufacturing services to Orgenesis, and to customers located within Israel and South Korea, respectively.

VR Resources Ltd (CSE:VRR) said the TSX Venture Exchange has accepted for filing documentation with respect to the non-brokered private placement it announced on August 2, The placing, with 27 placees, will see the issue of 2.2 million shares at a purchase price of 22 cents per share, and 1.1 million share purchase warrants to purchase 1.1 million share at an exercise price of 40 cents which expiry in 18 months. Meanwhile, The International Speculator, in its July 24, issue, said buy VR Resources at 13.5 cents - the newsletter's first buy of the stock.

Group Eleven Resources Corp. (CVE:ZNG) said the TSX Venture Exchange has accepted for filing the company's proposal to issue 120,000 shares at a deemed price of five cents per share in consideration of certain services provided to the company under an agreement dated May 7, 2019.

Xeris Biopharma Surpasses 2023 Expectations with Strategic Moves Poised for...

Xeris Biopharma CEO Paul Edick joined Steve Darling from Proactive to share news the company had a successful 2023, with a final tally of 164 million USD, which is at the upper end of their forecast. The company concluded the year with 72 million USD in cash, surpassing their initial projections...

7 hours, 58 minutes ago